Company name: Gaia Pharm
Description: Producer of cannabis products in Portugal. The company produces medical cannabis and derivative products.
Year founded: 2018
Industry: Consumer Products and Services (B2C) | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company reached a definitive agreement to be acquired by Aurora Cannabis (TSE: ACB) on February 26, 2019 for an undisclosed amount. The acquisition is consistent with Aurora’s strategy to achieve early mover advantage in countries with nascent medical cannabis markets. The company is being actively tracked by Cannapany.
Number of active investors:
Profile last updated: 2/26/2019
Last known valuation:
Last known valuation date: